The team at #EP Solutions would like to thank Prof Paul Wang, who founded the annual Stanford Biodesign Digital Health , New Arrhythmia Technologies Retreat more than twenty years ago, and Prof. Niraj Varma, of Cleveland Clinic , for updating the audience on the progress of EP Solutions' project at this year's retreat in Boston last week. EP Solutions is currently collecting clinical evidence to demonstrate that its innovative and noninvasive technology improves the clinical outcome of heart failure patients undergoing cardiac resynchronisation therapy. #EP #AI #CRT #HRS #noninvasive
Info
Brief history of the company: EP Solutions SA is a Swiss stock company founded in 2013 in Yverdon to further develop, industrialize and market the Amycard 01C electrophysiology workstation and its technology. Product: The Amycard 01C is an electrophysiology workstation featuring ECG recording of body surface electrograms, software for creating optimized 3D heart models from imaging and software for merging ECG data with the 3D volume model of the heart. The competitive advantage of the product is a 4 chambers 3D, real time recording of the electrical activity of the heart providing a quick availability of comprehensive cardiac excitation maps of epi- and endocardium. Reduced patient risk, optimized therapy outcome by enhancing diagnosis, less X-Ray exposure, shorter time in cath lab and savings on catheters
- Website
-
http://www.ep-solutions.ch
Externer Link zu EP Solutions
- Branche
- Herstellung medizinischer Geräte
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Yverdon-les-Bains, Vaud
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2013
- Spezialgebiete
- Electrophysiology, Mapping, Medical Device und R&D
Orte
-
Primär
Y-Parc
Avenue des Sciences 13
Yverdon-les-Bains, Vaud 1400, CH
Beschäftigte von EP Solutions
-
Ludwik Firek Ph.D.
Chief Medical Officer, EP-Solutions, Switzerland
-
Giovanni Esposito
Head of Product Development at EP Solutions
-
Konstantin Ushenin
Researcher in computational biomedicine with a background in deep learning, finite element analysis, and cardiac electrophysiology.
-
Vitaly Kalinin, MD, PhD
Сardiologist, Biomedical Engineer, Researcher
Updates
-
See you in Boston on Wednesday!
The Stanford Biodesign New Arrhythmia Technologies Retreat will take place in Boston on 15 May 2024. EP Solutions is proud to announce the presentation by Prof. Niraj Varma of Cleveland Clinic, who will update the audience on EP Solutions' clinical programme and product improvements. Marcin Gołębicki of EP Solutions will be in attendance and are looking forward to productive exchanges about improving heart failure patients' response to cardiac resynchronisation therapy. #crt #ecgi #heartfailure #stanfordbiodesign #hrs
-
The Stanford Biodesign New Arrhythmia Technologies Retreat will take place in Boston on 15 May 2024. EP Solutions is proud to announce the presentation by Prof. Niraj Varma of Cleveland Clinic, who will update the audience on EP Solutions' clinical programme and product improvements. Marcin Gołębicki of EP Solutions will be in attendance and are looking forward to productive exchanges about improving heart failure patients' response to cardiac resynchronisation therapy. #crt #ecgi #heartfailure #stanfordbiodesign #hrs
-
See you in Dublin on April 18th, our CEO Marcin Gołębicki will present our breakthrough #heartfailure technology saving patients and lowering cost of healthcare!
🍾 MedTech Strategist is honored to welcome EP Solutions alongside CEO Marcin Gołębicki as a Presenting Company at the 10th Annual Innovation Summit Dublin 2024. Presenting in the Cardiovascular Therapeutic Category, EP Solutions is based in Switzerland and develops a noninvasive planning tool that will boost the success rate of cardiac resynchronisation therapy, or CRT. Today, this life-saving device therapy for heart failure patients with an electric conduction disorder is successful in only 70% of cases. They aim to significantly improve this number and improve patients’ lives while reducing the economic, clinical and personal cost of non-response. They intend to become the provider of choice for a routine CRT planning tool, that is proven to improve outcome. 🥂 Welcome to #InnovationDublin24, EP Solutions and Marcin! 🤝 Celebrate 10 years of Innovation Summit in Dublin, Ireland April 16-18, 2024. Request to register now: https://bit.ly/48M8npY #medtech #medtechinnovation #medicaldevices #startups #heartfailure #cardiovascular #CRT
-
Last Tuesday, at LSI USA 2024 in Dana Point, Marcin Gołębicki, CEO of EP Solutions, delivered an insightful presentation on the company's approach to improve the clinical outcomes of cardiac resynchronization therapy. His talk sparked a lot of interest among attendees looking to advance cardiac care. If you were there and are intrigued by the investment opportunities this innovation presents, we will be delighted to meet and discuss further. Let's harness this momentum to transform the future of cardiac resynchronisation therapy together. Reach out to connect! #lsiusa24 #crt #heartfailure #noninvasive #medtech
-
We are thrilled to announce that our CEO, Marcin Golebicki, will be presenting at LSI 2024, the Emerging Medtech Summit, in Dana Point, California, on 19th March 2024 at 9.45. Marcin will introduce our groundbreaking noninvasive planning tool designed to enhance the outcomes of cardiac resynchronization therapy. This innovative approach promises to improve the lives of patients with heart failure, while reducing the cost of care, and we can't wait to share our insights with the medtech community. Interested in learning more ? Marcin would be delighted to meet with you at the event. Let's advance cardiac care together! #LSI2024 #Medtech #crt #ecgi #noninvasive
-
EP Solutions SA and Zign Innovations B.V. are thrilled to announce their strategic partnership. Our joint mission is to design and develop the next generation of noninvasive cardiac mapping systems, with a strong emphasis on clinical everyday usability and economics. This collaboration aims to advance technology and improve patient care by building upon our combined expertise in electronics, product development, and cardiac mapping systems. Our objective is to provide physicians with pre-implantation planning data that will improve the outcome of cardiac resynchronisation therapy, or CRT, in heart failure patients. The new system will focus on enhancing usability, a critical aspect in healthcare technology. By improving efficiency, error reduction and user satisfaction, we aim to create a system that is not only effective but also user-friendly for healthcare professionals. We are committed to making the system economically attractive, ensuring it contributes to reducing healthcare delivery costs by improving clinical outcomes. We look forward to sharing more updates as we progress on this exciting journey. Stay tuned! #heartfailure #crt #noninvasive #medicaldevice Frank Ambrosius Marco Stijn Marcin Gołębicki Nico Drost Alex van den Heuvel Adrian Maciejewski, M.D. Giovanni Esposito Matthias Egger
-
EP Solutions hat dies direkt geteilt
The ICONIC-M trial got off to a flying start in the new year: the first two heart failure patients, indicated for the implantation of a cardiac resynchronisation device, were implanted using EP Solutions’s pre-implantation planning tool. Congratulations to the implantation team at Maastricht UMC+, Twan van Stipdonk, Ömer Erküner, Claudia Zimmermann, Roelanda van Buggenum, radiologist Casper Mihl and Ludwik Firek Ph.D. from EP Solutions ! EP Solutions’ planning tool was used to help the implanting physicians identify the optimal position for left ventricular electrode lead placement. The multicentre, randomised, controlled ICONIC-M trial, led by principal investigator Niraj Varma, will assess its impact on clinical response to the therapy. EP Solutions aims to improve the lives of heart failure patients by providing physicians with personalised implantation plans for better outcomes. #crt #heartfailure #noninvasive
-
The ICONIC-M trial got off to a flying start in the new year: the first two heart failure patients, indicated for the implantation of a cardiac resynchronisation device, were implanted using EP Solutions’s pre-implantation planning tool. Congratulations to the implantation team at Maastricht UMC+, Twan van Stipdonk, Ömer Erküner, Claudia Zimmermann, Roelanda van Buggenum, radiologist Casper Mihl and Ludwik Firek Ph.D. from EP Solutions ! EP Solutions’ planning tool was used to help the implanting physicians identify the optimal position for left ventricular electrode lead placement. The multicentre, randomised, controlled ICONIC-M trial, led by principal investigator Niraj Varma, will assess its impact on clinical response to the therapy. EP Solutions aims to improve the lives of heart failure patients by providing physicians with personalised implantation plans for better outcomes. #crt #heartfailure #noninvasive
-
Congratulations to the Team at Maastricht University Medical Center, Kevin Vernooy, Twan van Stipdonk and Frederieke Eerenberg, for enrolling the first two patients in the ICONIC-M study ! ICONIC-M is a multicentre randomised controlled trial sponsored by EP Solutions and designed to assess the benefit of EP Solutions' non-invasive pre-implantation planning tool on the outcome of cardiac resynchronisation therapy (CRT). EP Solutions is focused on making CRT better and improving the lives of heart failure patients.